<VariationArchive RecordType="classified" VariationID="1185048" VariationName="NM_006265.3(RAD21):c.593dup (p.Ser198fs)" VariationType="Duplication" Accession="VCV001185048" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-08-07" MostRecentSubmission="2021-08-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1175000" VariationID="1185048">
      <GeneList>
        <Gene Symbol="RAD21" FullName="RAD21 cohesin complex component" GeneID="5885" HGNC_ID="HGNC:9811" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="116845934" stop="116874776" display_start="116845934" display_stop="116874776" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="117858172" stop="117887104" display_start="117858172" display_stop="117887104" Strand="-" />
          </Location>
          <OMIM>606462</OMIM>
          <Haploinsufficiency last_evaluated="2022-03-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD21">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-03-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD21">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006265.3(RAD21):c.593dup (p.Ser198fs)</Name>
      <CanonicalSPDI>NC_000008.11:116857361:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="116857361" stop="116857362" display_start="116857361" display_stop="116857362" variantLength="1" positionVCF="116857361" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="117869600" stop="117869601" display_start="117869600" display_stop="117869601" variantLength="1" positionVCF="117869600" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>S198fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_772" sequenceAccession="LRG_772">
            <Expression>LRG_772:g.22505dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.117869601dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.117869601dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.116857362dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.116857362dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032862.1" sequenceAccession="NG_032862" sequenceVersion="1" change="g.22505dup">
            <Expression>NG_032862.1:g.22505dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006265.3" sequenceAccession="NM_006265" sequenceVersion="3" change="c.593dup" MANESelect="true">
            <Expression>NM_006265.3:c.593dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006256.1" sequenceAccession="NP_006256" sequenceVersion="1" change="p.Ser198fs">
            <Expression>NP_006256.1:p.Ser198fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="606462.0010" DB="OMIM" />
        <XRef Type="rs" ID="2130469261" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006265.3(RAD21):c.593dup (p.Ser198fs) AND Cornelia de Lange syndrome 4" Accession="RCV001543704" Version="2">
        <ClassifiedConditionList TraitSetID="8701">
          <ClassifiedCondition DB="MedGen" ID="C3553517">Cornelia de Lange syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-07-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-08-07" MostRecentSubmission="2021-08-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24378232</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8701" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17306" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS</ElementValue>
                <XRef Type="MIM" ID="614701" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cornelia de Lange syndrome 4</ElementValue>
                <XRef ID="MONDO:0013864" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CDLS4</ElementValue>
                <XRef Type="MIM" ID="614701" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15837" />
                <XRef ID="15837" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C3553517" DB="MedGen" />
              <XRef ID="MONDO:0013864" DB="MONDO" />
              <XRef Type="MIM" ID="614701" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3466300" SubmissionDate="2021-07-30" DateLastUpdated="2021-08-07" DateCreated="2021-08-07">
        <ClinVarSubmissionID localKey="606462.0010_CORNELIA DE LANGE SYNDROME 4" title="RAD21, 2-BP DUP, NT592_CORNELIA DE LANGE SYNDROME 4" />
        <ClinVarAccession Accession="SCV001762405" DateUpdated="2021-08-07" DateCreated="2021-08-07" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 12-year-old boy (patient 2) with mild Cornelia de Lange syndrome-4 (CDLS4; 614701), Minor et al. (2014) identified a heterozygous 2-bp duplication (c.592_593dup, NM_006265) in exon 6 of the RAD21 gene, resulting in a frameshift and premature termination (Ser198ArgfsTer6). The mutation was identified by sequence analysis of the RAD21 gene. The mutation was not present in the mother, but the father was not available for testing. The mutation was predicted to result in either nonsense-mediated decay or a truncated protein missing functional domains necessary for the interaction with WAPL (610754), PDS5B (605333), and STAG1 (604358).</Attribute>
              <Citation>
                <ID Source="PubMed">24378232</ID>
              </Citation>
              <XRef DB="OMIM" ID="614701" Type="MIM" />
              <XRef DB="OMIM" ID="610754" Type="MIM" />
              <XRef DB="OMIM" ID="605333" Type="MIM" />
              <XRef DB="OMIM" ID="604358" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAD21" />
          </GeneList>
          <Name>RAD21, 2-BP DUP, NT592</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DUP, NT592</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606462.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CORNELIA DE LANGE SYNDROME 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3466300" TraitType="Disease" MappingType="Name" MappingValue="CORNELIA DE LANGE SYNDROME 4" MappingRef="Preferred">
        <MedGen CUI="C3553517" Name="Cornelia de Lange syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

